Skip to main content
Science Guru logo

International Conference on Biotechnology and Advanced Therapeutics

Call for Papers – ICBAT 2027, Billund

Billund, Denmark Conference home

Science Guru invites academicians, researchers, engineers, industry participants and students to submit original research papers to the International Conference on Biotechnology and Advanced Therapeutics (ICBAT-2027), held in Billund, Denmark on 20 March 2027.

Research tracks

Call for papers ICBAT 2027

Original research papers, abstracts, case studies and review papers are welcome. Topics include, but are not limited to:

Biotechnology Innovations in Therapeutics

  • Novel biopharmaceuticals and their development
  • Gene editing techniques for therapy
  • Targeted drug delivery systems

Ethical Considerations in Biotechnology

  • Regulatory frameworks for genetic therapies
  • Patient consent in biotechnological research
  • Ethical implications of gene editing

Sustainability in Biotherapeutic Production

  • Eco-friendly biomanufacturing processes
  • Waste reduction in biopharmaceuticals
  • Bio-based materials for therapeutic applications

Challenges in Therapeutic Development

  • Overcoming drug resistance in treatments
  • Scalability of biomanufacturing processes
  • Clinical trial design for new therapeutics

Interdisciplinary Approaches to Biotechnology

  • Collaboration between biology and engineering
  • Integration of AI in therapeutic developments
  • Translational research from bench to bedside

Timeline

Important dates of ICBAT 2027

  1. Paper submission deadline

  2. Early bird registration ends

  3. Last date of registration

  4. Date of conference

Registrations after the last date of registration may not be accepted. Questions? Email [email protected].

Contact

Contact the ICBAT 2027 team

Questions about submission, registration, the invitation letter or publication? Send us a message and the conference team will reply by email.

Security code image

Type the characters in the image.

We use your details only to answer you. See our privacy policy.